Sweden Hereditary Angioedema Market (2025-2031) | Growth, Share, Analysis, Value, Trends, Competitive Landscape, Outlook, Forecast, Industry, Size & Revenue, Companies, Segmentation

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Sweden Country Macro Economic Indicators

3.2 Sweden Hereditary Angioedema Market Revenues & Volume, 2021 & 2031F

3.3 Sweden Hereditary Angioedema Market - Industry Life Cycle

3.4 Sweden Hereditary Angioedema Market - Porter's Five Forces

3.5 Sweden Hereditary Angioedema Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 Sweden Hereditary Angioedema Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.7 Sweden Hereditary Angioedema Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Growing awareness about hereditary angioedema (HAE) among healthcare professionals and patients

4.2.2 Increasing research and development activities for innovative HAE treatments

4.2.3 Favorable government initiatives and policies supporting access to HAE therapies

4.3 Market Restraints

4.3.1 High cost associated with HAE treatments and therapies

4.3.2 Limited availability of specialized healthcare facilities for HAE diagnosis and management

4.3.3 Challenges in accurate diagnosis and differentiation of HAE from other similar conditions

6.1 Sweden Hereditary Angioedema Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 Sweden Hereditary Angioedema Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 Sweden Hereditary Angioedema Market Revenues & Volume, By C1 Esterase Inhibitor, 2021- 2031F

6.1.4 Sweden Hereditary Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F

6.1.5 Sweden Hereditary Angioedema Market Revenues & Volume, By Kallikrein Inhibitor, 2021- 2031F

6.1.6 Sweden Hereditary Angioedema Market Revenues & Volume, By Others, 2021- 2031F

6.2 Sweden Hereditary Angioedema Market, By Route of Administration

6.2.1 Overview and Analysis

6.2.2 Sweden Hereditary Angioedema Market Revenues & Volume, By Intravenous, 2021- 2031F

6.2.3 Sweden Hereditary Angioedema Market Revenues & Volume, By Subcutaneous Injection, 2021- 2031F

6.2.4 Sweden Hereditary Angioedema Market Revenues & Volume, By Oral, 2021- 2031F

6.3 Sweden Hereditary Angioedema Market, By Distribution Channel

6.3.1 Overview and Analysis

6.3.2 Sweden Hereditary Angioedema Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F

6.3.3 Sweden Hereditary Angioedema Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F

6.3.4 Sweden Hereditary Angioedema Market Revenues & Volume, By Others, 2021- 2031F

7.1 Sweden Hereditary Angioedema Market Export to Major Countries

7.2 Sweden Hereditary Angioedema Market Imports from Major Countries

8.1 Number of diagnosed HAE cases annually

8.2 Patient adherence to HAE treatment regimens

8.3 Rate of adoption of new HAE therapies in the market

9.1 Sweden Hereditary Angioedema Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 Sweden Hereditary Angioedema Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.3 Sweden Hereditary Angioedema Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10.1 Sweden Hereditary Angioedema Market Revenue Share, By Companies, 2024

10.2 Sweden Hereditary Angioedema Market Competitive Benchmarking, By Operating and Technical Parameters